Halting the Vicious Vortex: Case-based Discussions in Non-Cystic Fibrosis Bronchiectasis
Program Overview
Non-cystic fibrosis bronchiectasis (NCFBE) is an irreversible, chronic lung disease that is becoming increasingly prevalent and is a growing public concern. In this uniquely designed, interactive activity, a dynamic interprofessional panel of clinical experts will discuss NCFBE cases that have been crowdsourced from community clinicians, providing their insight on treatment strategies. Discussions between the 3 clinical experts will combine elements of evidence-based data and practical strategies to help you diagnose, treat, and monitor patients with NCFBE.
Pulmonology, radiology, and primary care clinicians managing patients with NCFBE
Educational Objectives
Upon completion of this activity, participants should be better able to:
Identify patient-related risk factors that should raise the clinical index of suspicion for non-cystic fibrosis bronchiectasis (NCFBE)
Utilize current criteria to readily diagnose patients with NCFBE
Apply conventional management approaches in patients with NCFBE
Analyze data supporting the role of neutrophil serine protease (NSP) in NCFBE pathophysiology and its utility as therapeutic target
Integrate the unique roles of the interprofessional care team when diagnosing and treating patients with NCFBE
Activity Faculty
Ashwin Basavaraj, MD, FCCP, ATSF
Assistant Professor, Medicine
NYU Grossman School of Medicine Section Chief, Pulmonary, Critical Care and Sleep Medicine
Bellevue Hospital Center Associate Director, Bronchiectasis and NTM Program
NYU Langone Health
New York, NY
Charles L. Daley, MD
Chief, Division of Mycobacterials and Respiratory Infections Professor, Medicine
National Jewish Health
Denver, CO
Amy L. Springer, MSN, FNP-C
Pulmonary Nurse Practitioner
NYU Langone Health
New York, NY